NewslettersImmunology of Infectious Disease News A Long-Acting Formulation of Rifabutin Is Effective for Prevention and Treatment of Mycobacterium tuberculosis By Danielle Corrigan - August 8, 2022 0 Scientists showed the development of long-acting injectable drug formulations of the anti-Tuberculosis drug rifabutin made of biodegradable polymers and biocompatible solvents that solidified after subcutaneous injection. [Nature Communications] Full Article